Should smoking be an indication for lipid-lowering therapy?

Med J Aust. 1999 Mar 1;170(5):240. doi: 10.5694/j.1326-5377.1999.tb140342.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Anticholesteremic Agents / economics
  • Anticholesteremic Agents / therapeutic use*
  • Australia
  • Cholesterol / blood
  • Coronary Disease / prevention & control
  • Guidelines as Topic
  • Humans
  • Hyperlipidemias / drug therapy*
  • Insurance, Health / economics
  • Middle Aged
  • Risk Factors
  • Smoking*

Substances

  • Anticholesteremic Agents
  • Cholesterol